PAM
ACET icon

Panagora Asset Management’s Adicet Bio ACET Stock Holding History

Panagora Asset Management’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,450
Closed -$54.5K – 1186
2024
Q1 		$54.5K Sell
1,450
-1,784
-55% -$73.8K ﹤0.01% 1194
2023
Q4 		$97.8K Buy
+3,234
New +$70.5K ﹤0.01% 1205
2022
Q3 		– Sell
-1,050
Closed -$245K – 1422
2022
Q2 		$245K Buy
+1,050
New +$231K ﹤0.01% 1358
2021
Q3 		– Sell
-34
Closed -$6K – 1703
2021
Q2 		$6K Buy
+34
New +$6.92K ﹤0.01% 2414
2020
Q2 		– Sell
-322
Closed -$37K – 2553
2020
Q1 		$37K Buy
322
+201
+166% +$29.8K ﹤0.01% 1948
2019
Q4 		$20K Buy
+121
New +$61.3K ﹤0.01% 2039

Other funds holding ACET

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Panagora Asset Management's ACET Position: Q2 2024 in Review

Panagora Asset Management sold out of Adicet Bio (ACET) in Q2 2024, closing a stake of 1,450 shares — an estimated $54.5K sold.

Panagora Asset Management first reported a position in ACET in Q4 2019 and held it in 6 quarters. The position peaked at $245K in Q2 2022. 86 funds tracked by Wall St. Rank hold ACET as of Q2 2024.

  • Panagora Asset Management reported no remaining Adicet Bio position as of Q2 2024 after selling out during the quarter.
  • Panagora Asset Management sold 1,450 Adicet Bio shares in Q2 2024, an estimated $54.5K.
  • Panagora Asset Management first reported a position in Adicet Bio in Q4 2019 and held it in 6 quarters.
  • Panagora Asset Management's Adicet Bio position peaked at $245K in Q2 2022.
  • 86 funds tracked by Wall St. Rank held Adicet Bio as of Q2 2024.

Based on Panagora Asset Management's 13F filing for Q2 2024, filed 29 Jul 2024.